MAM
QTTB icon

Meeder Asset Management’s Q32 Bio QTTB Stock Holding History

Meeder Asset Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-11
Closed -$3K – 2524
2020
Q1 		$3K Buy
+11
New +$3.37K ﹤0.01% 2008
2019
Q2 		– Sell
-11
Closed -$5K – 2163
2019
Q1 		$5K Sell
11
-3
-21% -$1.34K ﹤0.01% 1411
2018
Q4 		$5K Buy
+14
New +$5.29K ﹤0.01% 1426

Other funds holding QTTB

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Meeder Asset Management's QTTB Position: Q2 2020 in Review

Meeder Asset Management sold out of Q32 Bio (QTTB) in Q2 2020, closing a stake of 11 shares — an estimated $3K sold.

Meeder Asset Management first reported a position in QTTB in Q4 2018 and held it in 3 quarters. The position peaked at $5K in Q1 2019. 102 funds tracked by Wall St. Rank hold QTTB as of Q2 2020.

  • Meeder Asset Management reported no remaining Q32 Bio position as of Q2 2020 after selling out during the quarter.
  • Meeder Asset Management sold 11 Q32 Bio shares in Q2 2020, an estimated $3K.
  • Meeder Asset Management first reported a position in Q32 Bio in Q4 2018 and held it in 3 quarters.
  • Meeder Asset Management's Q32 Bio position peaked at $5K in Q1 2019.
  • 102 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2020.

Based on Meeder Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.